Imaging test for protein loss in digestive cancer patients
Part of Cancer, Digestive system clinical trials.
This trial uses a special PET/CT scan with a radioactive tracer (68Ga-HSA) to see if it can help detect protein-losing enteropathy in people with digestive system tumors. It aims to provide a new way to diagnose this condition that causes low protein levels in the blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a digestive system tumor (such as stomach, colon, or pancreatic cancer).
- You have low protein levels in your blood or symptoms of low protein (like swelling or fluid buildup).
- Your blood albumin level is less than 30 g/L, and your alpha-1 antitrypsin level in stool is more than 80 ml per day.
- You have a tumor that can be seen on standard imaging scans (like CT or MRI).
- Your doctor expects you to live at least 3 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan tracer to see where immune system signals are active in people with cancer. It may help doctors understand how your immune system is responding to the disease.
This study tests an imaging method that looks for PD-L1 (a protein linked to some cancers) in solid tumors, including gastrointestinal cancers. It may help doctors better see where PD-L1 is in the body using a scan.
This study tests a new type of imaging scan (called 68Ga-NYM207 PET/CT) that may help doctors better find and understand liver cancer. You would receive the scan once to see if it helps doctors plan your treatment or monitor your cancer.
This trial studies an imaging tracer that targets HER2, a protein that can be found in certain cancers. It may help doctors see where HER2-positive tumors are in the body using scans.
This study uses a special scan (molecular imaging) to see how well antibody-drug conjugates (ADCs) work in people with breast cancer. It may help doctors choose the right treatment for you.
This trial uses a special imaging test (PET scan) to find digestive system cancers. It uses molecules that attach to cancer cells so they light up on the scan, which may help doctors see tumors more clearly.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.